Official 2024 U.S. DOL Form 5500 summary for Mylan Pharmaceuticals INC. (Mylan Pharmaceuticals INC. 401(k) Defined Contribution Plan · EIN 55-0455423 · PN 005): $41.89M net assets, 81 active participants, and $0.19 per $10,000 (0.19 bps).
| Plan Sponsor | Mylan Pharmaceuticals INC. |
|---|---|
| Filing Identifier | Mylan Pharmaceuticals INC. 401(k) Defined Contribution Plan · EIN 55-0455423 · PN 005 |
| Plan Category & State | 401(k) Defined Contribution (PA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $41.89M |
| Active Participants | 81 |
| Direct Admin Fee Rate | $0.19 per $10,000 (0.19 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Bank of America / Merrill |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($2,150, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI